Table 3.
Association of discharge BNP and discharge GDF‐15 level (analysed as continuous variables) with 2‐year mortality: multivariate model
| HR (95% CI) | P‐value | |
|---|---|---|
| Discharge GDF‐15 (per 100 ng/mL) | 1.02 (1.00–1.03) | 0.04 |
| Discharge BNP (per 100 pg/mL) | 1.01 (1.00–1.02) | 0.04 |
| Age (per year) | 1.02 (0.99–1.04) | 0.12 |
| Male | 1.59 (0.91–2.75) | 0.10 |
| Discharge creatinine (per mg/dL) | 1.11 (0.77–1.59) | 0.59 |
| Discharge haemoglobin (per g/dL) | 0.88 (0.78–1.00) | 0.05 |
| Discharge C‐reactive protein (per mg/L) | 1.00 (0.99–1.01) | 0.70 |
| Left ventricular systolic function < 40% | 0.88 (0.52–1.49) | 0.64 |
| Discharge NYHA class≥III | 0.97 (0.52–1.81) | 0.92 |
BNP, B‐type natriuretic peptide; CI, confidence interval; GDF‐15, growth differentiation factor 15; HR, hazard ratio; NYHA, New York Heart Association.